144 related articles for article (PubMed ID: 23489199)
1. In vivo anticancer activity of methotrexate-loaded layered double hydroxide nanoparticles.
Choi SJ; Oh JM; Chung HE; Hong SH; Kim IH; Choy JH
Curr Pharm Des; 2013; 19(41):7196-202. PubMed ID: 23489199
[TBL] [Abstract][Full Text] [Related]
2. In vivo pharmacological evaluation and efficacy study of methotrexate-encapsulated polymer-coated layered double hydroxide nanoparticles for possible application in the treatment of osteosarcoma.
Ray S; Saha S; Sa B; Chakraborty J
Drug Deliv Transl Res; 2017 Apr; 7(2):259-275. PubMed ID: 28050892
[TBL] [Abstract][Full Text] [Related]
3. Biocompatible nanoparticles intercalated with anticancer drug for target delivery: pharmacokinetic and biodistribution study.
Choi SJ; Oh JM; Choy JH
J Nanosci Nanotechnol; 2010 Apr; 10(4):2913-6. PubMed ID: 20355523
[TBL] [Abstract][Full Text] [Related]
4. Anticancer drug-inorganic nanohybrid and its cellular interaction.
Kim JY; Choi SJ; Oh JM; Park T; Choy JH
J Nanosci Nanotechnol; 2007 Nov; 7(11):3700-5. PubMed ID: 18047040
[TBL] [Abstract][Full Text] [Related]
5. Intracellular drug delivery of layered double hydroxide nanoparticles.
Oh JM; Park CB; Choy JH
J Nanosci Nanotechnol; 2011 Feb; 11(2):1632-5. PubMed ID: 21456254
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional nanoparticles as somatostatin receptor-targeting delivery system of polyaniline and methotrexate for combined chemo-photothermal therapy.
Nguyen HT; Phung CD; Thapa RK; Pham TT; Tran TH; Jeong JH; Ku SK; Choi HG; Yong CS; Kim JO
Acta Biomater; 2018 Mar; 68():154-167. PubMed ID: 29292170
[TBL] [Abstract][Full Text] [Related]
7. Pluronic mixed micelles overcoming methotrexate multidrug resistance: in vitro and in vivo evaluation.
Chen Y; Sha X; Zhang W; Zhong W; Fan Z; Ren Q; Chen L; Fang X
Int J Nanomedicine; 2013; 8():1463-76. PubMed ID: 23620663
[TBL] [Abstract][Full Text] [Related]
8. Orthogonally functionalized nanoscale micelles for active targeted codelivery of methotrexate and mitomycin C with synergistic anticancer effect.
Li Y; Lin J; Wu H; Chang Y; Yuan C; Liu C; Wang S; Hou Z; Dai L
Mol Pharm; 2015 Mar; 12(3):769-82. PubMed ID: 25625539
[TBL] [Abstract][Full Text] [Related]
9. Functionalized Lipid-Polymer Hybrid Nanoparticles Mediated Codelivery of Methotrexate and Aceclofenac: A Synergistic Effect in Breast Cancer with Improved Pharmacokinetics Attributes.
Garg NK; Tyagi RK; Sharma G; Jain A; Singh B; Jain S; Katare OP
Mol Pharm; 2017 Jun; 14(6):1883-1897. PubMed ID: 28402673
[TBL] [Abstract][Full Text] [Related]
10. The in vivo antitumor activity of LHRH targeted methotrexate-human serum albumin nanoparticles in 4T1 tumor-bearing Balb/c mice.
Taheri A; Dinarvand R; Ahadi F; Khorramizadeh MR; Atyabi F
Int J Pharm; 2012 Jul; 431(1-2):183-9. PubMed ID: 22531853
[TBL] [Abstract][Full Text] [Related]
11. The effects of drug transporter inhibitors on the pharmacokinetics and tissue distribution of methotrexate in normal and tumor-bearing mice: a microdialysis study.
Sani SN; Henry K; Böhlke M; Kim J; Stricker-Krongrad A; Maher TJ
Cancer Chemother Pharmacol; 2010 May; 66(1):159-69. PubMed ID: 19816684
[TBL] [Abstract][Full Text] [Related]
12. Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier.
Han JH; Oh YK; Kim DS; Kim CK
Int J Pharm; 1999 Oct; 188(1):39-47. PubMed ID: 10528081
[TBL] [Abstract][Full Text] [Related]
13. A novel platform designed by Au core/inorganic shell structure conjugated onto MTX/LDH for chemo-photothermal therapy.
Tian DY; Wang WY; Li SP; Li XD; Sha ZL
Int J Pharm; 2016 May; 505(1-2):96-106. PubMed ID: 26997424
[TBL] [Abstract][Full Text] [Related]
14. Anionic clay as the drug delivery vehicle: tumor targeting function of layered double hydroxide-methotrexate nanohybrid in C33A orthotopic cervical cancer model.
Choi G; Piao H; Alothman ZA; Vinu A; Yun CO; Choy JH
Int J Nanomedicine; 2016; 11():337-48. PubMed ID: 26855572
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate Nanoparticles Prepared with Codendrimer from Polyamidoamine (PAMAM) and Oligoethylene Glycols (OEG) Dendrons: Antitumor Efficacy in Vitro and in Vivo.
Zhao Y; Guo Y; Li R; Wang T; Han M; Zhu C; Wang X
Sci Rep; 2016 Jul; 6():28983. PubMed ID: 27388443
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro evaluation of pH-sensitive magnetic nanocomposites as methotrexate delivery system for targeted cancer therapy.
Wu J; Deng A; Jiang W; Tian R; Shen Y
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():132-140. PubMed ID: 27987687
[TBL] [Abstract][Full Text] [Related]
17. Convection-enhanced delivery of methotrexate-loaded maghemite nanoparticles.
Corem-Salkmon E; Ram Z; Daniels D; Perlstein B; Last D; Salomon S; Tamar G; Shneor R; Guez D; Margel S; Mardor Y
Int J Nanomedicine; 2011; 6():1595-602. PubMed ID: 21904449
[TBL] [Abstract][Full Text] [Related]
18. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and Tissue Distribution of Folate-Decorated Human Serum Albumin Loaded With Nano-Hydroxycamptothecin for Tumor Targeting.
Wang W; Liang H; Sun B; Xu J; Zeng Z; Zhao X; Li Q
J Pharm Sci; 2016 Jun; 105(6):1874-1880. PubMed ID: 27129905
[TBL] [Abstract][Full Text] [Related]
20. PEG capped methotrexate silver nanoparticles for efficient anticancer activity and biocompatibility.
Muhammad Z; Raza A; Ghafoor S; Naeem A; Naz SS; Riaz S; Ahmed W; Rana NF
Eur J Pharm Sci; 2016 Aug; 91():251-5. PubMed ID: 27132812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
